Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
Clinical trial NCT01285310 · TERMINATED
Trial details
- NCT number
- NCT01285310
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-09
- Primary completion
- 2012-02-21
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.